As direct-to-consumer ketamine prescriptions obtained via telehealth in the United States, along with psychedelic support, proliferate, some patients are turning to general-purpose chatbots as de facto "therapists" in unmonitored settings. These AI-guided altered-state sessions carry significant ethical, clinical, and legal risks. Current AI tools are not licensed professionals, lack consistent...
Preliminary research shows the psychedelic psilocybin to be a promising potential treatment for psychiatric illnesses. Recent U.S. government legislation and policy indicate that access to psilocybin, which remains illegal on the federal level despite increasing efforts to decriminalize it at the state and local levels, will be expanded to enable further research into its treatment potential....